Deficiency of tumour necrosis factor-related apoptosis-inducing ligand exacerbates lung injury and fibrosis

BACKGROUND: The death receptor ligand tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) shows considerable clinical promise as a therapeutic agent. TRAIL induces leukocyte apoptosis, reducing acute inflammatory responses in the lung. It is not known whether TRAIL modifies chronic lung...

Descripción completa

Detalles Bibliográficos
Autores principales: McGrath, Emmet E, Lawrie, Allan, Marriott, Helen M, Mercer, Paul, Cross, Simon S, Arnold, Nadine, Singleton, Vanessa, Thompson, Alfred A R, Walmsley, Sarah R, Renshaw, Stephen A, Sabroe, Ian, Chambers, Rachel C, Dockrell, David H, Whyte, Moira K B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2012
Materias:
Interstitial Lung Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426075/
https://www.ncbi.nlm.nih.gov/pubmed/22496351
http://dx.doi.org/10.1136/thoraxjnl-2011-200863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426075/
https://www.ncbi.nlm.nih.gov/pubmed/22496351
http://dx.doi.org/10.1136/thoraxjnl-2011-200863

Ejemplares similares